First Manhattan’s AtriCure ATRC Stock Holding History

First Manhattan’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500	Closed	-$20K	–	1509
2022 Q2	$20K	Hold	500	–	–	﹤0.01%	1107
2022 Q1	$32K	Hold	500	–	–	﹤0.01%	1078
2021 Q4	$34K	Hold	500	–	–	﹤0.01%	1069
2021 Q3	$34K	Hold	500	–	–	﹤0.01%	1058
2021 Q2	$39K	Sell	500 -200	-29%	-$14.5K	﹤0.01%	1031
2021 Q1	$45K	Sell	700 -300	-30%	-$18.5K	﹤0.01%	974
2020 Q4	$55K	Hold	1,000	–	–	﹤0.01%	886
2020 Q3	$39K	Hold	1,000	–	–	﹤0.01%	918
2020 Q2	$44K	Hold	1,000	–	–	﹤0.01%	892
2020 Q1	$33K	Hold	1,000	–	–	﹤0.01%	927
2019 Q4	$32K	Hold	1,000	–	–	﹤0.01%	969
2019 Q3	$24K	Hold	1,000	–	–	﹤0.01%	1018
2019 Q2	$29K	Hold	1,000	–	–	﹤0.01%	1012
2019 Q1	$26K	Hold	1,000	–	–	﹤0.01%	1055
2018 Q4	$30K	Hold	1,000	–	–	﹤0.01%	1002
2018 Q3	$35K	Hold	1,000	–	–	﹤0.01%	1038
2018 Q2	$27K	Hold	1,000	–	–	﹤0.01%	1055
2018 Q1	$20K	Sell	1,000 -19,000	-95%	-$343K	﹤0.01%	1099
2017 Q4	$364K	Hold	20,000	–	–	﹤0.01%	592
2017 Q3	$447K	Hold	20,000	–	–	﹤0.01%	552
2017 Q2	$485K	Hold	20,000	–	–	﹤0.01%	533
2017 Q1	$383K	Buy	+20,000	New	+$350K	﹤0.01%	570

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

First Manhattan's ATRC Position: Q3 2022 in Review

First Manhattan sold out of AtriCure (ATRC) in Q3 2022, closing a stake of 500 shares — an estimated $20K sold.

First Manhattan first reported a position in ATRC in Q1 2017 and held it in 22 quarters. The position peaked at $485K in Q2 2017. 214 funds tracked by Wall St. Rank hold ATRC as of Q3 2022.

First Manhattan reported no remaining AtriCure position as of Q3 2022 after selling out during the quarter.
First Manhattan sold 500 AtriCure shares in Q3 2022, an estimated $20K.
First Manhattan first reported a position in AtriCure in Q1 2017 and held it in 22 quarters.
First Manhattan's AtriCure position peaked at $485K in Q2 2017.
214 funds tracked by Wall St. Rank held AtriCure as of Q3 2022.

Based on First Manhattan's 13F filing for Q3 2022, filed 14 Nov 2022.